arotinolol has been researched along with Malignant Hypertension in 2 studies
arotinolol: structure given in first source; arotinolol is the (+-)-isomer
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakamoto, H | 2 |
Nemoto, H | 2 |
Sugahara, S | 2 |
Okada, H | 2 |
Suzuki, H | 2 |
1 trial available for arotinolol and Malignant Hypertension
Article | Year |
---|---|
Nifedipine and arotinolol in combination for accelerated-malignant hypertension: results of one year follow-up.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Calcium Channel Blockers; Dru | 1999 |
1 other study available for arotinolol and Malignant Hypertension
Article | Year |
---|---|
Control of blood pressure and prevention of end-organ damage in patients with accelerated hypertension by combination with arotinolol and extended release nifedipine.
Topics: Adrenergic beta-Antagonists; Adult; Biopsy; Blood Pressure; Calcium Channel Blockers; Creatinine; De | 2000 |